SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001618835-22-000135
Filing Date
2022-06-07
Accepted
2022-06-07 08:45:37
Documents
1
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165460592338998.html 3  
1 FORM 3 wf-form3_165460592338998.xml 3 5165
  Complete submission text file 0001618835-22-000135.txt   6642
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12400 HIGH BLUFF., STE. 600 SAN DIEGO CA 92130
Business Address
Atkinson Katherine Cocca (Reporting) CIK: 0001929747 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36754 | Film No.: 22999927